Literature DB >> 7388563

Intermittent claudication: is a supervised exercise class worth while?

P C Clifford, P W Davies, J A Hayne, R N Baird.   

Abstract

Twenty-one patients (19 men and two women) with disabling exercise-related leg pain attended a physiotherapy department on one afternoon each week for an exercise training programme lasting one month. The clinical diagnosis of intermittent claudication and localisation of the atherosclerotic occlusions were confirmed in all but one case by pulse volume recordings and segmental Doppler systolic pressure measurements. Two patients whose symptoms worsened underwent arterial reconstruction. Post-training assessment at six months showed that the remaining 18 patients walked 80% further and performed 75% more step-ups. They also felt much healthier, having unduly restricted their activities before because they had feared the onset of ischaemic leg pain. These results suggest that supervised exercise training is a simple and effective method of treating patients with intermittent claudication.

Entities:  

Mesh:

Year:  1980        PMID: 7388563      PMCID: PMC1601659          DOI: 10.1136/bmj.280.6230.1503

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  Treatment of gangrene of the feet and legs by walking.

Authors:  W T FOLEY
Journal:  Circulation       Date:  1957-05       Impact factor: 29.690

2.  A diet and exercise regimen: its effect upon mental acuity and personality, a pilot study.

Authors:  C F Merzbacher
Journal:  Percept Mot Skills       Date:  1979-04

3.  Effect of daily muscular exercise in patients with intermittent claudication.

Authors:  O A Larsen; N A Lassen
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

4.  Enzyme activity and fiber composition in skeletal muscle of untrained and trained men.

Authors:  P D Gollnick; R B Armstrong; C W Saubert; K Piehl; B Saltin
Journal:  J Appl Physiol       Date:  1972-09       Impact factor: 3.531

5.  Effect of physical training on different categories of patients with intermittent claudication.

Authors:  T Jonason; B Jonzon; I Ringqvist; A Oman-Rydberg
Journal:  Acta Med Scand       Date:  1979

6.  Exercise and intermittent claudication.II. Effect of physical training.

Authors:  J S Skinner; D E Strandness
Journal:  Circulation       Date:  1967-07       Impact factor: 29.690

7.  The fate of patients with intermittent claudication managed nonoperatively.

Authors:  F F McAllister
Journal:  Am J Surg       Date:  1976-11       Impact factor: 2.565

8.  Physical training of patients with intermittent claudication: indications, methods, and results.

Authors:  R Ekroth; A G Dahllöf; B Gundevall; J Holm; T Scherstén
Journal:  Surgery       Date:  1978-11       Impact factor: 3.982

  8 in total
  6 in total

1.  Claudication.

Authors:  V C Ruckley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

Review 2.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

3.  Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

4.  The natural history of chronic leg ischemia.

Authors:  M A McGrath; A R Graham; D A Hill; R S Lord; G D Tracy
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

5.  Diagnosis and monitoring in arterial surgery: the use of ultrasound and related techniques.

Authors:  R N Baird
Journal:  Ann R Coll Surg Engl       Date:  1982-03       Impact factor: 1.891

6.  The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.

Authors:  Timothy P Murphy; Alan T Hirsch; John J Ricotta; Donald E Cutlip; Emile Mohler; Judith G Regensteiner; Anthony J Comerota; David J Cohen
Journal:  J Vasc Surg       Date:  2008-04-25       Impact factor: 4.268

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.